CV Lattes
ResearcherID
Universidade de São Paulo (USP). Faculdade de Medicina (FM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduated in Pharmacy by Universidade Federal da Paraíba (UFPB, 1995), master degree in Sciences (Microbiology) by Instituto de Ciências Biomédicas, Universidade de São Paulo (ICB USP, 2002), Ph.D. in Sciences (Dermatology) by Faculdade de Medicina, Universidade de São Paulo (FMUSP, 2008) and specialization in Medical Mycology (2000) and Advanced Immunology (2009) by Institut Pasteur de Paris. He worked as a researcher with vaccine preclinical trials anti-SIV in non-human primates in the Service d'Immuno-Virologie Laboratoire des Thérapies Innovantes et de Prévention des Infections Virales, in Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA), France, from 2009 june to 2011 december. Currently, he is postdoctoral degree in the HIV / AIDS in the Laboratory of Investigation in Dermatology and Immunodeficiencies (LIM 56), Faculty of Medicine of the USP. Great experience in Immunopathology and Mycology areas, with emphasis on HIV infection and pathogenics fungi. Researches: immune responses to HIV / Aids, HIV vaccines, superficial and systemic mycoses and dermatophytosis. Presently, he is a health analyst by the municipal government of São Paulo, working as a pharmacist at the Hospital Municipal e Maternidade Prof. Mario Degni since April 2019. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The HIV/Aids pandemic is one of the most important in the last decades without a vaccine or effective treatment has been developed in order to stop the infection and / or viral transmission to present. Actually, 36.9 million people living with HIV/Aids, according to UNAIDS. To develop a HIV vaccine or new forms of effective treatment is a global priority. In a minority of HIV-infected ind…
The global HIV/Aids pandemic is one of the most important in the last decades. Since it was discovery, Aids have affected more than 60 million people and have killed over 25 million mostly in developing countries. It is a priority to obtain an HIV vaccine or new forms of effective treatments as well as discover new correlates of protection against the virus in all regions of the world. Un…
| 4 / 2 | Completed scholarships in Brazil |
| Associated processes | |